Andy Shrago is Chairman of the Board of Proxim Diagnostics Corp. He also serves as a board member for Pinpoint Software and HDL Diagnostics. From 2011-2016, he was a co-manager of the Madison based Wisconsin Investment Partners angel network. Prior to that, he was Senior VP of Sales and Marketing for Prodesse, a biotech start-up that focused on molecular diagnostics for infectious disease and was sold to Gen-Probe (San Diego, CA) for $72 million. Andy has an MBA from the University of Chicago and a BA from Cornell University.